載入...
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
Introduction: Hematopoietic neoplasms are often driven by gain-of-function mutations of the JAK-STAT pathway together with mutations in chromatin remodeling and DNA damage control pathways. The interconnection between the JAK-STAT pathway, epigenetic regulation or DNA damage control is still poorly...
Na minha lista:
| 發表在: | Expert Opin Ther Targets |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5743003/ https://ncbi.nlm.nih.gov/pubmed/29148847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2018.1406924 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|